Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $1.20 | Prev. Close $1.18 | Circuit Range N/A |
Day Range $1.20 - $1.20 | Year Range $0.05 - $2.41 | Volume 725 |
Average Traded $1.20 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $1.18 | $1.18 | +18.59% |
02-Apr-26 | $0.99 | $0.99 | -1.49% |
01-Apr-26 | $0.98 | $1.01 | +2.54% |
31-Mar-26 | $0.98 | $0.98 | +5.35% |
30-Mar-26 | $0.94 | $0.94 | +10.39% |
27-Mar-26 | $0.86 | $0.85 | -19.33% |
26-Mar-26 | $1.11 | $1.05 | -4.55% |